United Nations(PTI): The World Health Organisation has said that it is continuing to monitor several descendent lineages of the Omicron variant of the coronavirus, including two new sublineages that have additional mutations associated with potential "immune escape characteristics.
The COVID-19 Weekly Epidemiological Update, released by WHO on Tuesday, said that the Omicron variant remains the dominant variant circulating globally.
WHO said it continues to monitor several descendent lineages under the Omicron Variant of Concern, including BA.1, BA.2, BA.3 as well as now BA.4 and BA.5. It also includes BA.1/BA.2 circulating recombinant forms, such as XE.
A small number of sequences of BA.4 and BA.5 descendent lineages have now been detected in a few countries. Both have additional mutations in the Spike region (S:L452R, S:F486V) and unique mutations outside of Spike. The S:L452R and S:F486V mutations are associated with potential immune escape characteristics," the global health organisation said.
It added that it is working with scientists to further assess the characteristics of these lineages and their public health implications. WHO recommends countries to continue surveillance, where possible, and rapid data sharing on publicly available databases.
According to WHO, the SARS-CoV-2 virus continues to evolve. With such intense transmission worldwide, further variants, including recombinants, will emerge. This is expected."
WHO is tracking the two new sublineages (BA.4 and BA.5) as part of the Omicron variant.
These variants have additional mutations that need to be further studied to understand their impact on immune escape potential. Only a few dozen sequences of these variants have been reported from a handful of countries.
WHO is working with scientists to better understand their current spread as well as any potential impact they may have.
WHO said that Omicron's properties of immune escape have been associated with the rapid and almost synchronous increase in the global incidence of COVID-19 cases reported until the end of January 2022.
A further increase observed at the beginning of March was driven primarily by a delayed increase in case incidences in the Western Pacific Region and a rebound in the number of new cases reported in the European Region.
"This trend was likely due to a combination of factors, including the predominance of the Omicron Pango lineages BA.1, and then BA.2, with a transmission advantage over other Omicron lineages; relaxation of public health and social measures (PHSM); and waning of humoral immunity following vaccination and/or prior infection," it said.
"The recent detection of emerging recombinants of the Delta-Omicron and Omicron descendent lineages requires ongoing close monitoring.
The WHO update added that globally, during the week of April 4 through 10, the number of new COVID-19 cases and deaths has continued to decline for a third consecutive week, with over 7 million cases and over 22,000 deaths reported, a decrease of 24 per cent and 18 per cent respectively, as compared to the previous week.
All regions reported decreasing trends in the number of new weekly cases and deaths. As of April 10, over 496 million confirmed cases and over 6 million deaths have been reported globally.
These trends should be interpreted with caution as several countries are progressively changing their COVID-19 testing strategies, resulting in lower overall numbers of tests performed and consequently lower numbers of cases detected, it said.
Over 11 billion vaccine doses have been distributed globally. WHO however noted that substantial inequities remain, with only 11 per cent of those in low-income countries (LICs) having completed the primary series; and major differences among regions, with vaccination coverage ranging from 82 per cent in the Western Pacific Region to 13 per cent in the African Region.
There is particular concern about reaching the most vulnerable populations who remain unvaccinated, particularly those of older age and those with comorbidities, it said, adding that globally, an estimated 35 per cent of those aged 60 years and over are awaiting completion of the primary vaccination series.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jerusalem (PTI): India and Israel on Thursday elevated their "time-tested" relationship to a special strategic partnership and agreed to soon firm up a "mutually beneficial" free trade deal even as Prime Minister Narendra Modi strongly backed the Gaza peace initiative, asserting that humanity must never become a victim of conflict.
Following talks between Modi and his Israeli counterpart Benjamin Netanyahu, the two sides inked a plethora of agreements to expand cooperation in areas of trade, agriculture, energy, cyberspace and digital payment.
India and Israel also vowed to expand their already close defence partnership by working towards joint development and joint production of military hardware under the framework of the transfer of technologies.
In his media statement, Modi said India's security interest is linked to peace and stability in the Middle East, adding that New Delhi fully supports the Gaza Peace Initiative.
"India's stance is clear: humanity must never become a victim of conflict. A path to peace has been created through the Gaza Peace Plan. India has fully supported these efforts," he said.
"In the future as well, we will continue dialogue and cooperation with all countries," he said.
PM Modi landed in Israel on Wednesday on a two-day visit. It is his second visit to Israel in nine years.
In his remarks, the prime minister said India and Israel have a united view that there is no place for terrorism in the world and both sides stand shoulder-to-shoulder in countering terrorism and its supporters.
"Our relationship is founded on the strong bedrock of deep trust, shared democratic values, and human sensitivities. Our bond has stood the test of every trial of time," he said.
"Today, we have taken the historic decision to elevate our time-tested partnership to the status of a 'Special Strategic Partnership'," he said.
The prime minister also announced the establishment of an India-Israel critical and emerging technologies partnership to impart a new momentum for cooperation in areas of artificial intelligence, quantum, and critical minerals. "I am pleased that an agreement has been reached for the use of UPI in Israel," he said.
The prime minister, referring to the threat of terrorism, said India and Israel will continue to confront the menace unitedly.
"India and Israel are completely clear that there is no place for terrorism in the world. In any form, in any expression, terrorism cannot be accepted," he said.
"We have stood shoulder-to-shoulder in opposing terrorism and its supporters, and we will continue to do so," he added.
India and Israel also discussed the implementation of the India-Middle East Europe Economic Corridor (IMEC) and cooperation under the framework of I2U2 (India-Israel-UAE-USA).
